As part of an application to the EIC Pathfinder Open 2026 call, EU-based industrial partners are sought to support scale-up, regulatory development, and first-in-human clinical translation of innovative small-molecule modulators and targeted nanomedicine platforms. Dual-action technologies selectively influence mitochondrial and bacterial ion pathways to reprogram tumor immunity and gut microbiota, boosting the efficacy of anti-Programmed death-1 (PD-1) immunotherapy.
Ref. BOFR20260318036 Empresa francesa que ofrece una alternativa 100% reciclada al hormigón y la piedra busca socios comerciales.
A young French industrial company, founded in 2021, develops and commercializes an innovative construction material made entirely from recycled inputs. Designed to replace concrete and natural stone in outdoor developments, the material supports a fully...
Abr 27, 2026
















